Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Levetiracetam long-term follow-up in pediatric partial onset seizures
NCT00152516Phase 3Completed
- Sponsor
- UCB
- Start
- Oct 2004
- Primary completion
- Jun 2008
- Modality
- Small Molecules
- Countries
- 16
01
Overview
Phase 3, open-label, single-arm trial of levetiracetam in focal onset seizure, sponsored by UCB. Primary endpoint: Percentage Change (Reduction) of Partial (Type I) Seizure Frequency Per Week From Baseline at 48 weeks. Started Oct 2004; status: completed.
02
Drugs
levetiracetam
03
Conditions
focal onset seizure
Beyond the preview
Go deeper on NCT00152516.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00152516.